# Eliminating HCV Infection Among PWUD

> **NCT05474781** · — · UNKNOWN · sponsor: **Vancouver Infectious Diseases Centre** · enrollment: 300 (estimated)

## Conditions studied

- Hepatitis C, Chronic
- Drug Use

## Interventions

- **DRUG:** Epclusa

## Key facts

- **NCT ID:** NCT05474781
- **Lead sponsor:** Vancouver Infectious Diseases Centre
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02-22
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2022-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05474781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05474781, "Eliminating HCV Infection Among PWUD". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05474781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*